If COVID-19-induced cytokines trigger COVAN in individuals with APOL1 HRG, why did SARS-CoV-2 vaccine, which also increase systemic cytokines, not increase the incidence of glomerulopathy in individuals with APOL1 HRG? The gene discussed is APOL1; the disease is lipoprotein glomerulopathy.